Medicare delays remote monitoring ban until 2029 to allow providers time
Medicare regulators announced a two-year delay for a controversial plan banning third-party remote patient monitoring services, pushing the implementation date to 2029.
Category: Health
Study finds medical records often miss women’s reported health struggles
A recent study paired electronic medical records with interviews of 87 women to compare documented data against their lived experiences in the United States.
Americans remain largely unaware of kratom and its synthetic derivatives despite rising public health concerns
A new survey by the Annenberg Public Policy Center reveals that most Americans have never heard of kratom or understand the distinction between its natural form and potent synthetic versions sold in stores.
Researchers describe life with asymptomatic Alzheimer’s disease
A scientist at the Penn Memory Center explains the unique experience of people living with cognitively unimpaired Alzheimer's disease pathology.
English Heritage saves Jenner’s historic smallpox vaccination hut
English Heritage has secured Edward Jenner's original Gloucestershire garden hut where he performed the first smallpox vaccinations in 1796.
Health minister orders pause to Phone First service cuts
Northern Ireland's health minister has instructed trusts to pause planned cuts to the Phone First telephone triage service effective immediately.
Pope Leo XIV starts Latin America tour three weeks after lung surgery
Pope Leo XIV began a twelve-day trip to Uruguay, Argentina and Peru on Friday, November 6, just three weeks following lung cancer surgery.
Dallas Cowboys honor Marshawn Kneeland one year after his death
Dallas Cowboys players reflected on their mental health program and remembered teammate Marshawn Kneeland on the anniversary of his death in Frisco, Texas.
Trump administration takes over 500 actions to weaken cancer protections
A new October report alleges the Trump administration has implemented more than 500 actions to dismantle federal carcinogen protections.
Revolution Medicines Rasonque drug sales hit $198 million in five weeks
Revolution Medicines reported that its pancreatic cancer drug Rasonque generated $198 million in U.S. sales during the first five weeks after receiving regulatory approval.